Semaglutide — Class II drug recall D-0608-2025
Ongoing recall by Boothwyn Pharmacy LLC, reported 2025-09-10, distributed nationwide. Subpotent Drug
| Recall number | D-0608-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Boothwyn Pharmacy LLC, Kennett Square, PA, United States |
| Recall initiated | 2025-07-09 |
| Classified | 2025-08-29 |
| Reported by FDA | 2025-09-10 |
| Distributed | Nationwide (US) |
| Quantity | 186 vials |
| Reason classes | potency |
| Expiration dates | 2025-07-18 |
Product
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0608-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.